INTERNATIONAL PATENT: GENZYME CORPORATION FILES APPLICATION FOR "VENGLUSTAT AS AN INHIBITOR OF GLUCOSYLCERAMIDE SYNTHASE IN SUBJECTS HAVING HEPATIC IMPAIRMENT"

GENEVA, Dec. 29 -- GENZYME CORPORATION (450 Water StreetCambridge, Massachusetts 02141) filed a patent application (PCT/IB2025/056136) for "VENGLUSTAT AS AN INHIBITOR OF GLUCOSYLCERAMIDE SYNTHASE IN SUBJECTS HAVING HEPATIC IMPAIRMENT" on Jun 16, 2025. With publication no. WO/2025/262570, the details related to the patent application was published on Dec 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CARTOT COTTON, Sylvaine (c/o Sanofi, Patent Department450 Water StreetCambridge, Massachusetts 02141), SHARMA, Jyoti (c/o Sanofi, Patent Department450 Water StreetCambridge, Massachusetts 02...